Position in VOR
as of Sep 30, 2026
· filed Oct 2, 2026
Position Value
$13,890
New position
Shares Held
728
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Sep 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Sep 30, 2026Versant Capital Management, Inc holds $6,648,536 across 141 Biotechnology names. VOR ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,886 | $668,166 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,098 | $574,045 | |
| 3 | MRNA |
Moderna, Inc.
|
2,491 | $479,691 | |
| 4 | GMAB |
Genmab A/S
|
12,235 | $436,483 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
534 | $404,916 | |
| 6 | ARGX |
Argenx SE
|
414 | $396,988 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,704 | $188,121 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
652 | $160,874 |
All Filings in VOR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $13,890 | 728 | Shares | Sole | 2026-10-02 | |
| No filing history on record for this holder in this stock. | ||||||